Revive Therapeutics (Canada)
Revive Therapeutics Ltd. (CSE: RVV, USA: RVVTF) is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of
Basic Information
- Category: business
- Website: http://www.revivethera.com/
Documented Facts
- Inception (Wikidata): 2012 (Source 3: Wikidata Q50038149, revision 2474210951)
- Country (Wikidata; date unspecified): Canada (Source 3: Wikidata Q50038149, revision 2474210951; Source 4: Wikidata label: Q16, revision 2555105353)
- Official website (Wikidata; date unspecified): http://www.revivethera.com/ (Source 3: Wikidata Q50038149, revision 2474210951)
Evidence and Sources
- Revive Therapeutics (Canada) — Official Site (official)
- Revive Therapeutics (Canada) on instagram (social)
- Wikidata Q50038149, revision 2474210951 (knowledge-base)
- Wikidata label: Q16, revision 2555105353 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Revive Therapeutics (Canada).
- Canonical profile: https://brandsource.ai/brands/revive-therapeutics-canada
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/revive-therapeutics-canada/json-ld
- Citation profile API: https://brandsource.ai/api/brands/revive-therapeutics-canada/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Revive Therapeutics Ltd. (CSE: RVV, USA: RVVTF) is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Emergency Use Authorization, Orphan Drug, Fast Track, and Breakthrough Therapy designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.